—Diane Rosman, biotechnology professional
—Guy Rosman, technical scientist with Rylem, owner of Ramps To You
—Fuqiang Ruan, principal scientist, discovery chemistry, Ikaria
—Alex Rudolph, associate scientist, Gilead Sciences
—Jennifer Running Deer, senior associate scientist, Novo Nordisk
—Anthony Russell, director of medical affairs, ZymoGenetics
—Chanchal Sadhu, senior principal investor, Covance Laboratories
—Stephen Schmidt, biochemical pharmacology, Genentech
—Lisa Schultze, head of quality, Saltigo Redmond
—James Schwartz, director of business operations and sales effectiveness, ZymoGenetics
—Randy Schweikart, senior manager, Amgen
—Vicki Schweickart, principal at Datakine Consulting
—Roxanne Scott, drug safety consultant [Added 12/30/09]
—Nilesh Shah, principal scientist, Seattle Genetics
—Regan Shea, senior director of chemical development, Gilead Sciences
—Kim Shigenaka, senior associate scientist, Amgen
—Randall Sittner, logistics manager at Seattle Genetics, owner Kim’s Cafe
—Elaine Skeffington, executive assistant, Institute for Systems Biology
—Karen Solvason, clinical data management, Seattle Genetics
—Jari Sowell, senior data manager, Genentech [Updated, 12/30/09, formerly with Amgen]
—Diane St. John, director of human resources, Seattle Genetics
—Tom St. John, former executive vice president, Fate Therapeutics
—Frank Stappenbeck, scientist, Fate Therapeutics
—Don Staunton, president and chief scientific officer, CisThera
—Michael Stein, member of the board of directors, Nautilus
—Bart Steiner, staff scientist, Calistoga Pharmaceuticals
—Michael Stewart, president, Northwest Pharma Consulting
—Johnny Stine, founder and president, North Coast Biologics
—Cliff Stocks, chief business officer, Calistoga Pharmaceuticals
—Ellen Stone, benefits manager, Symetra Financial
